Ginkgo biloba for Attention-Deficit/Hyperactivity Disorder in children and adolescents: A double blind, randomized controlled trial

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 1, 2010, Pages 76-80

  Salehi, Bahman ^a   Imani, Reza ^b   Mohammadi, Mohammad Reza ^b   Fallah, Jalil ^b   Mohammadi, Mohammad ^b   Ghanizadeh, Ahmad ^c   Tasviechi, Ali Akbar ^b   Vossoughi, Ardalan ^b   Rezazadeh, Shams Ali ^d   Akhondzadeh, Shahin ^b  

^a ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Institute of Medicinal Plants Iran   (Iran)

Author keywords

Attention Deficit Hyperactivity Disorder; Clinical trial; Ginkgo biloba; Methylphenidate

Indexed keywords

GINKGO BILOBA EXTRACT; GINKO TD; METHYLPHENIDATE; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADOLESCENT; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECREASED APPETITE; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; EVENING DOSAGE; FEMALE; HUMAN; INSOMNIA; LONELINESS; MALE; MORNING DOSAGE; NAUSEA; NERVOUSNESS; PARALLEL DESIGN; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SIDE EFFECT; TREATMENT OUTCOME; WEIGHT REDUCTION; XEROSTOMIA;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; GINKGO BILOBA; HUMANS; MALE; METHYLPHENIDATE; PHYTOTHERAPY; PLANT PREPARATIONS; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME;

EID: 73649122761     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2009.09.026     Document Type: Article

References (26)

1. Akhondzadeh S. Herbal medicine in the treatment of psychiatric and neurological disorders. In: L'Abate L. (Ed). Low-cost approaches to promote physical and mental health: theory research and practice (2007), Springer, New York 119-138
2. Akhondzadeh S., Tavakolian R., Davari-Ashtiani R., Arabgol F., and Amini H. Selegiline in the treatment of attention-deficit hyperactivity disorder in children: a double-blind and randomized trial. Prog Neuropsychopharmacol Biol Psychiatry 27 (2003) 841-845
3. Akhondzadeh S., Mohammadi M.R., and Khademi M. Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371]. BMC Psychiatry 8 4 (2004) 9
4. Akhondzadeh S., Mohammadi M.R., and Momeni F. Passiflora incarnata in the treatment of attention-deficit hyperactivity disorder in children and adolescents. Therapy 2 (2005) 609-614
5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition (2000), American Psychiatric Association, Washington, DC Text Revision
6. Amiri S., Mohammadi M.R., Mohammadi M., Nouroozinejad G.H., Kahbazi M., and Akhondzadeh S. Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: a double blind, randomized clinical trial. Prog Neuropsychopharmacol Biol Psychiatry 32 (2008) 145-149
7. Banaschewski T., Roessner V., Dittmann R.W., Santosh P.J., and Rothenberger A. Non-stimulant medications in the treatment of ADHD. Eur Child Adolesc Psychiatry 13 (2004) 102-116
8. Birks J., and Grimley Evans J. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev 21 (2009) CD003120
9. Canter P.H., and Ernst E. Ginkgo biloba is not a smart drug: an updated systematic review of randomized clinical trials testing the nootropic effects of G. biloba extracts in healthy people. Hum Psychopharmacol 22 (2007) 265-278
10. Cormier E. Attention deficit/hyperactivity disorder: a review and update. J Pediatr Nurs 23 (2008) 345-357
11. Curatolo P., Paloscia C., D'Agati E., Moavero R., and Pasini A. The neurobiology of attention deficit/hyperactivity disorder. Eur J Paediatr Neurol 13 (2009) 299-304
12. Dopheide J.A., and Pliszka S.R. Attention-deficit-hyperactivity disorder: an update. Pharmacotherapy 29 (2009) 656-679
13. DuPaul G., Power T., Anastopoulos A., and Reid R. ADHD Rating Scale-IV (1998), Guilford, New York
14. Frei H. Ginkgo biloba and attention deficit hyperactivity disorder in children: open study to investigate the efficacy and tolerability of a plant remedy. Schweiz Z Ganzheitsmed 14 (2002) 10-13
15. Ghanizadeh A., Mohammadi M.R., and Yazdanshenas A. Psychometric properties of the Farsi translation of the Kiddie Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version. BMC Psychiatry 15 6 (2006) 10
16. Huguet F., and Tarrade T. Alpha-2-adrenoceptor changes during cerebral ageing. The effect of Ginkgo biloba extract. J Pharm Pharmacol 44 (1992) 24-27
17. Kahbazi M., Ghoreishi A., Rahiminejad F., Mohammadi M.R., Kamalipour A., and Akhondzadeh S. A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder. Psychiatry Res 168 (2009) 234-237
18. Lyon M.R., Cline J.C., Totosy de Zepetnek J., Shan J.J., Pang P., and Benishin C. Effect of the herbal extract combination Panax quinquefolium and Ginkgo biloba on attention-deficit hyperactivity disorder: a pilot study. Psychiatry Neurosci 26 (2001) 221-228
19. Mohammadi M.R., and Akhondzadeh S. Attention-deficit/hyperactivity disorder: etiology and pharmacotherapy. Exp Rev Neurotrapeutics 7 (2007) 195-201
20. Nathan P. Can the cognitive enhancing effects of Ginkgo biloba be explained by its pharmacology?. Med Hypotheses 55 (2000) 491-493
21. Noorbala A.A., and Akhondzadeh S. Attention-deficit/hyperactivity disorder: etiology and pharmacotherapy. Arch Iranian Med 9 (2006) 374-380
22. Ponto L.L., and Schultz S.K. Ginkgo biloba extract: review of CNS effects. Ann Clin Psychiatry 15 (2003) 109-119
23. Richard W., Root I.I., Robert J., and Resnick J. An update on the diagnosis and treatment of Attention-Deficit/Hyperactivity Disorder in children. Prof Psychol Res Pract 34 (2003) 34-41
24. Sawni A. Attention-deficit/hyperactivity disorder and complementary/alternative medicine. Adolesc Med State Art Rev 19 (2008) 313-326
25. White H., Scates P., and Cooper B. Extracts of Ginkgo biloba leaves inhibit monoamine oxidase. Life Sci 58 (1996) 1315-1321
26. Winter J.C., and Timineri D. The discriminative stimulus properties of EGb 761, an extract of Ginkgo biloba. Pharmacol Biochem Behav 62 (1999) 543-547